Elite Pharmaceuticals, Inc. (ELTP)
ELTP Stock Price Chart
Explore Elite Pharmaceuticals, Inc. interactive price chart. Choose custom timeframes to analyze ELTP price movements and trends.
ELTP Company Profile
Discover essential business fundamentals and corporate details for Elite Pharmaceuticals, Inc. (ELTP) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
24 Feb 2000
Employees
64.00
Website
https://www.elitepharma.comCEO
Nasrat Hakim
Description
Elite Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and manufacture of oral, controlled-release products and generic pharmaceuticals. The company operates in two segments, Abbreviated New Drug Applications for Generic Products and New Drug Applications for Branded Products. It owns, licenses, and contract manufactures various generic and oral dose pharmaceuticals products, such as Phentermine HCl 37.5mg tablets for the treatment of bariatrics under Adipex-P brand; Phendimetrazine Tartrate 35mg tablets for bariatrics under the Bontril brand; Naltrexone HCl 50mg tablets for the treatment of pains under the Revia brand; and Isradipine 2.5mg and 5mg capsules for cardiovascular diseases. The company also provides Oxycodone HCl immediate release 5mg, 10mg, 15mg, 20mg, and 30mg tablets for pains under Roxycodone brand; Trimipramine Maleate Immediate Release antidepressant capsules under the Surmontil brand; Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Immediate Release tablets for central nervous system diseases under the Adderall brand, as well as Dantrolene Sodium capsules for muscle relaxant under the Dantrium brand; SequestOX, an immediate release Oxycodone with Naltrexone; Loxapine Succinate capsules for treating antipsychotic under the brand Loxapine; Acetaminophen and Codeine Phosphate for the management of mild to moderate pain; and antibiotic products. In addition, it manufactures controlled-release products on a contract basis for third parties in the areas of pain, allergy, bariatric, and infection. Further, the company is developing a range of abuse deterrent opioid products. The company was incorporated in 1997 and is headquartered in Northvale, New Jersey.
ELTP Financial Timeline
Browse a chronological timeline of Elite Pharmaceuticals, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 Feb 2026
Upcoming earnings on 13 Nov 2025
Earnings released on 14 Aug 2025
EPS came in at -$0.01 , while revenue for the quarter reached $40.21M .
Earnings released on 30 Jun 2025
EPS came in at $0.01 , while revenue for the quarter reached $32.00M .
Earnings released on 13 Feb 2025
EPS came in at -$0.01 , while revenue for the quarter reached $14.36M .
Earnings released on 14 Nov 2024
EPS came in at -$0.01 , while revenue for the quarter reached $18.88M .
Earnings released on 1 Jul 2024
EPS came in at $0.00 , while revenue for the quarter reached $18.80M , missing expectations by -37.96%.
Earnings released on 29 Jun 2024
EPS came in at $0.00 , while revenue for the quarter reached $17.95M , missing expectations by -40.78%.
Earnings released on 14 Feb 2024
EPS came in at $0.00 , while revenue for the quarter reached $15.54M , missing expectations by -48.73%.
Earnings released on 14 Nov 2023
EPS came in at $0.01 , while revenue for the quarter reached $14.16M , missing expectations by -53.29%.
Earnings released on 14 Aug 2023
EPS came in at $0.00 , while revenue for the quarter reached $8.98M .
Earnings released on 29 Jun 2023
EPS came in at -$0.00 , while revenue for the quarter reached $8.64M .
Earnings released on 14 Feb 2023
EPS came in at $0.00 , while revenue for the quarter reached $9.25M .
Earnings released on 15 Nov 2022
EPS came in at $0.00 , while revenue for the quarter reached $8.59M .
Earnings released on 15 Aug 2022
EPS came in at $0.00 , while revenue for the quarter reached $7.67M .
Earnings released on 29 Jun 2022
EPS came in at $0.01 , while revenue for the quarter reached $7.67M .
Earnings released on 14 Feb 2022
EPS came in at $0.00 , while revenue for the quarter reached $8.97M .
Earnings released on 15 Nov 2021
EPS came in at $0.00 , while revenue for the quarter reached $8.56M .
Earnings released on 16 Aug 2021
EPS came in at $0.00 , while revenue for the quarter reached $7.06M .
Earnings released on 14 Jun 2021
EPS came in at -$0.00 , while revenue for the quarter reached $4.40M .
Earnings released on 16 Feb 2021
EPS came in at $0.00 , while revenue for the quarter reached $6.05M .
Earnings released on 16 Nov 2020
EPS came in at $0.00 , while revenue for the quarter reached $7.40M .
ELTP Stock Performance
Access detailed ELTP performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.